Mission
While drug discovery is advancing exponentially, drug development is utterly outdated. Until now.
Biotech has never been more innovative. mRNA technology has changed how we make vaccines, CRISPR is rewriting the genome, and there are hundreds of AI drug discovery startups promising to fundamentally transform how we discover new potential medicines.Yet despite this immense innovation, drug development remains stuck in the past.
While research labs and startups buzz with modern tech and AI, drug development trudges along as it did decades ago–manual, fragmented, excruciatingly slow, and unbearably expensive. Surging demand for development resources coupled with growing capacity constraints threaten to stall the very innovations in research that could bring life-saving medicines to patients.
Dash Bio was founded to shatter this barrier.
We are a passionate team of industry veterans with firsthand experience leveraging tech to transform biopharma R&D. We are rebuilding drug development from the ground up with a tech-first approach, leveraging AI, robotics, and fully integrated software to fundamentally reinvent the way drugs are brought to market.
Imagine a world where collaboration with sponsors is intuitive, data flows seamlessly, and bringing a drug to market is faster than ever before. This is the future we’re building.